Drugs & Diseases

Recent Drug Updates

  • semaglutide (Ozempic) FDA approved long-acting GLP-1 receptor agonist for type 2 diabetes
  • evolocumab (Repatha) First PCSK9 Inhibitor approved to prevent MI, stroke, and coronary revascularization in adults with established CVD
  • trastuzumab-dkst (Ogivri) FDA approves first biosimilar to Herceptin for patients with HER2-overexpressing breast or metastatic stomach cancer

Slideshow Collections

  • Chronic Alcohol Abuse: Complications and Consequences People who chronically abuse alcohol are at increased risk for cirrhosis, GI bleeding, pancreatitis, cardiomyopathy, trauma, mental health disorders, and a wide variety of cancers. Learn more about the potentially devastating complications of excessive, long-term alcohol use.
  • Idiopathic Pulmonary Fibrosis IPF is a chronic, progressive fibrosing interstitial pneumonia of unknown cause that primarily occurs in older adults. How do you identify and manage this frequently fatal condition?
  • Obesity: How to Diagnose and Treat an Epidemic The adverse consequences of obesity are much more complex than simply being an imbalance between energy intake and energy output. Learn the pathophysiology behind this epidemic and how to diagnose and treat this multifactorial disease.
  • Seasonal Affective Disorder (SAD): Facts and Misconceptions Popular misconceptions notwithstanding, seasonal affective disorder (SAD) is not a separate disease but a manifestation of the seasonality of affective illness. It is part of a mood cycle that also includes manic symptoms. How can you most effectively manage this cycle?